• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Alcon partners with actress Kate Walsh on US launch of Systane dry eye drops


The partnership is in support of the company's latest dry eye relief campaign and part of the launch for its leading global artificial tear drop brand.

Kate Walsh

Image courtesy of Alcon

Alcon is partnering with actress Kate Walsh as part of the launch for its Systane Complete Preservative-Free Lubricant Eye Drops for the treatment of dry eye, the company announced Thursday.

As part of the Alcon’s new Make Every Look Count campaign, Walsh will share her personal experience with how dry eye has impacted her life and the positive effect the company’s dry eye product has had on relieving symptoms.

According to Walsh, the goal of the campaign is to encourage those with dry eye to find what works for their symptoms “so they can reconnect with loved ones and the experiences in life that matter most,” she said in a news release.

Systane Complete Preservative-Free Lubricant Eye Drops works by hydrating and supporting all layers of the tear film, providing 8 hours of relief for dry eye symptoms after application of one drop.

Intelligent moisture and lipid delivery is used to enhance dispersion across the surface of the eye to stabilize the tear film, the company stated.

Its nano-droplet technology allows for fast-acting hydration, tear evaporation protection, and long-lasting relief for a patient’s eyes.

The bottle’s closing tip system was designed using patented PureFlow technology to ensure safe delivery of the artificial tear.

It has a one-way valve so no contaminated liquid is re-introduced into the container after a drop has been dispensed, eliminating the need for preservatives in the eye drops.

The product was launched in Europe earlier this year, with plans to extend to Australia and additional markets later in 2022.

“The addition of Systane Complete Preservative-Free to our portfolio means we can expand options and deliver real, long-lasting relief to help people see brilliantly at a time when dry eye symptoms are on the rise,” said Sean Clark, general manager, US Vision Care at Alcon, in a statement.

See more dry eye coverage

Related Videos
Andrew Pucker, OD, PhD
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Marc R Bloomenstein, OD, FAAO, chats with Optometry Times about the benefits of Vevye in the treatment of dry eye
R Tracy Williams, OD, FAAO, details his experience as a sports team optometrist
© 2024 MJH Life Sciences

All rights reserved.